Through the collaboration, Genezen will offer access to 4basebio’s synthetic DNA developed specifically for viral vector applications, creating a more streamlined path for cell and gene therapy ...
Dublin, April 20, 2026 (GLOBE NEWSWIRE)-- The "Viral Vector and Plasmid DNA Manufacturing Market (7th Edition): Industry Trends and Global Forecasts, till 2035" report has been added to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results